British Society for Haematology. Listening. Learning. Leading British Society for Haematology. Listening. Learning. Leading
020 7713 0990
Annual Scientific Meeting
Login
Sign Up
Apply for Membership Website Registration
BSH 60th Anniversary
020 7713 0990
  • About Us
    • Board of Trustees
    • Committees
      • Communications
      • BSH Enterprises
      • Education
      • External Affairs
      • Finance Audit and Risk Committee
      • Guidelines
      • Programme
      • Research and Grants
      • Nominations, Governance and Awards Committee
    • Special Interest Groups
      • Global Haematology SIG
      • Lymphoma SIG
      • Teenage and Young Adult SIG
      • Obstetric Haematology SIG
      • Paediatric SIG
      • Laboratory SIG
    • Awards and Prizes
    • Contact Us
    • Website FAQs
    • Articles of Association, Regulation and Signed Accounts
    • Get involved
    • Work for us
  • Education
    • BSH Education resources
      • Case Reports
      • Multiple Choice Questions
      • Essay Questions
      • Extended Matching Questions
    • Haematology images
    • Other organisations
    • Students
    • Submit content
    • Lectures and Videos
      • Annual Scientific Meeting 2019
        • Presentations
        • Pitfalls 2019 Presentations
        • Guidelines Session
      • Annual Scientific Meeting 2018
        • Presentations
        • Pitfalls - 2018
      • EHA 2018 - Interviews
      • BSH Trainees Day: Genomics in Practice
      • ASH 2018 - Speaker Videos
      • Previous Pitfall Lectures and Videos
      • Patient Perspective: The journey of Pain in Sickle Cell Disease
      • COVID-19 Webinars
    • Conference and events
      • Events
      • Annual Scientific Meeting
      • Promote your haematology event
      • Event Terms and Conditions
      • Crucible Prize
      • Event FAQs
      • Haematology for the Workforce of the Future 2022
    • Genomics
      • Genomics Videos
      • Genomics Resources
    • Demonstration Videos
  • Grants
    • Annual Scientific Meeting Scholarships
    • ASH-BSH Abstract Achievement Award
    • Cohort Study Grant
    • Early-Stage Research Start-up Grants
    • Global Haematology Scholarship
    • Meeting Support
    • Student Elective Scholarships
    • Trainee Educational Bursaries
    • Travel Scholarships
    • Visiting Fellow
    • Grants - our impact
    • Grants FAQs
  • Guidelines
    • About our Guidelines
    • Proposing and writing a new BSH Guideline
    • Sounding Board
  • Membership
    • Membership Signup
    • Meet our members
    • Member updates
    • Your career and wellbeing
    • British Journal of Haematology
    • BSH-EHA Joint Membership
    • Membership FAQs
    • Event Proposal
    • Membership Survey 2020
  • News
    • COVID-19 Updates
  • BSH at 60
    • Haematology timeline
    • 60 at 60 Exhibition
    • BSH Past Presidents
    • Multidisciplinary Haematology Team
    • Building a Community
    • Overcoming Obstacles
    • Inspiring Others
    • Enhancing Care
    • Pioneering Research
    • BSH 2020 Gallery
    • Acknowledgements
  • Workforce
    • Workforce report: Key Points
  • Home
  • HTML Sitemap

HTML Sitemap

  • About Us
  • Board of Trustees
  • Committees
  • Communications
  • BSH Enterprises
  • Education
  • External Affairs
  • Finance Audit and Risk Committee
  • Guidelines
  • Transfusion Task Force
  • General Haematology Task Force
  • Haemato–Oncology Task Force
  • Haemostasis and Thrombosis Task Force
  • Programme
  • Research and Grants
  • Nominations, Governance and Awards Committee
  • Special Interest Groups
  • Global Haematology SIG
  • Global Haematology SIG Plenary Speaker Project
  • Health Volunteers Overseas (HVO) Scheme
  • Lymphoma SIG
  • Teenage and Young Adult SIG
  • Obstetric Haematology SIG
  • Paediatric SIG
  • Laboratory SIG
  • News
  • Essential Haematology Day
  • Member login
  • New AML genes discovered
  • 2017 Clinical Excellence Awards Round
  • Applications open to become the next BSH Student Representative
  • Participate in the national Blood Transfusion and Blood Donation Survey
  • RCP publish Future Hospital Programme report
  • Applications invited for the position of Editor-in-Chief British Journal of Haematology
  • Register now and save up to £150
  • Abstract submissions for the BSH Annual Scientific Meeting 2018
  • A HaemSTAR is born
  • Survey reveals current UK practice of managing Hodgkin’s lymphoma in older patients
  • Applications open for L'Oreal-UNESCO Women in Science Awards
  • Digital digest
  • Ibrutinib non-responders may benefit from combination therapy for CLL
  • Digital digest - 2 February
  • HSF1 blockers promising for multiple myeloma
  • DNA repair and packaging genes linked to multiple myeloma risk
  • BSH Blood Transfusion Guidelines used in NBTC Blood Components App
  • Digital digest - 9 February
  • Ageing immune system ‘key to cancer development risk’
  • Hybrid-capture sequencing backed for lymphoid cancer
  • Digital digest - 16 February
  • Latest radiotherapy device will fine-tune bone marrow irradiation
  • BSH member Dr Amit Sud awarded haematology research medal
  • Progress predicted in haemoglobin disorder care
  • Landmark CAR T-cell study results published
  • Warning over anticoagulant use for atrial fibrillation in CKD
  • Digital digest - 23 February
  • Imaging tools reveals inner structure of red blood cells
  • Celebrating Success: BSH member part of haematology department awarded Myeloma UK service award
  • Promise for novel treatment in severe bleeding disorder
  • Digital Digest - 2 March
  • Age does not affect NHL survival after HCT
  • STAT5 inhibitor could target oncogenic pathway in leukaemia
  • Increased heart failure risk for breast cancer and lymphoma patients
  • Mixed-phenotype acute leukaemia patients benefit from less toxic therapy
  • International women's day 2018: Meet some of our women members making a difference in haematology
  • Digital Digest - 20 April
  • Former BSH President Allan Victor Hoffbrand wins Sultan Bin Khalifa International Thalassemia Grand International Award
  • Cardiovascular risks faced by child cancer survivors
  • Clue to future ALL relapse
  • Headway in development of lymphoma epigenetics therapeutics
  • BSH becomes sponsor and partner of Health Volunteers Overseas
  • Stored blood ‘less safe’ for some patients
  • Warning as blood stocks stay low
  • BSH announces Professor Simon Rule as new Vice President
  • Scientists get stem cells through... the snow
  • Rare disease patients need Europe - MPs
  • Applications are now open for NHS England’s Clinical Entrepreneurs Programme
  • New therapeutic targets for aggressive diffuse large B-cell lymphoma
  • Warfarin alternatives effective for catheter ablation
  • Anaemia risks maternal death
  • Applications open for Chief Scientific Officer's Knowledge Transfer Partnership programme for leaders in healthcare science
  • Annual Scientific Meeting - Join the social media campaign
  • New VTE prevention guidance for over-16s
  • Professor John Barrett MD appointed as Editor-in-Chief of British Journal of Haematology
  • Genetic variation and biomarkers may help predict brain injury risk in paediatric ALL
  • Gene fusion an early event in childhood leukaemia
  • Chronic graft-versus-host disease gene regulation insight
  • ‘Organic gene therapy’ approach suggested for red cell disorders
  • New cancer drug class unveiled at Imperial
  • Genetic alterations in multiple myeloma revealed
  • Novel epigenetic link to blood cancer
  • NHS genomics project “at risk” - MPs
  • BSH announces Professor Cheng-Hock Toh as President
  • Special Resolution to adopt updated articles
  • Digital Digest - 11 May
  • Bloodwise Highlights from the BSH Annual Scientific Meeting 2018
  • NHS preparing to offer CAR-T therapy to patients
  • ‘Young, Black and Stigmatised’ - Dr Sonia Wolf wins inaugural Crucible Prize
  • Progress towards universal red cell source
  • Meta-analysis reveals best treatments for post-partum haemorrhage
  • The Aplastic Anaemia Trust are inviting grant applications as they launch new research strategy
  • Genetic profiling of blood samples could help personalise multiple myeloma treatment
  • Genomic analysis could help patients with DLBCL
  • Type O blood ‘increases risk of death from trauma’
  • World Thalassaemia Day – Time of new hope?
  • BSH celebrating International Nurses Day 2018
  • Introducing Professor Cheng-Hock Toh - BSH President's first message
  • Step towards biomarker that predicts CAR T cell therapy response
  • Senior haematologists have called on NHS England to reverse restrictions on using ibrutinib to treat relapsed chronic lymphocytic leukaemia
  • CPD budget cuts affecting nursing skills - Royal College of Nursing
  • Tablet hope for cancer-related VTE
  • Genome sequencing allows improved blood transfusion matching
  • Inflammatory signalling protein plays key role in AML
  • Haemophilia survey highlights fears
  • ALL gene-environment interaction points to hygiene factor
  • How haemophilia nursing care is evolving
  • European trial of new leukaemia drug pairing
  • Reprogrammed cells could correct haemophilia B
  • Genomic atlas of human plasma proteome unveiled
  • BSH celebrate World Blood Donor Day 2018
  • Chief Executive of the Sickle Cell Society is awarded an OBE in the Queen’s Birthday Honours.
  • Bone marrow recreated in lab
  • Gene editing of healthy cells offers prospect for CAR T treatment of AML
  • World Sickle Cell Day - Dr Sonia Wolf Q&A
  • What is Sickle Cell Disease (SCD)?
  • Football key to blood donor recruitment
  • New target to fight Fanconi anaemia
  • GP urgent cancer referrals increase sharply
  • Message from BSH President
  • Lymphoma risk from myelofibrosis treatment
  • Blood cancer therapy toxicity examined
  • New drugs are improving survival times for patients with aggressive type of blood cancer
  • BSH Celebrating 70 years of the NHS
  • Sepsis research targets vascular leakage
  • New drugs improve MCL patient survival times
  • Leukaemia virus changes DNA packaging
  • DOACs a safe alternative to warfarin
  • EMA approves CAR T-cell therapies in milestone decision
  • Former BSH President Dr Patrick Carrington interviewed on BBC 5 Live for NHS 70th Anniversary
  • Contaminated blood inquiry truth promise
  • Gene therapy hope for Hunter syndrome
  • Genetic changes in blood predict AML risk
  • Biomedical science day 2018 - Meet BSH Member Dr Maria Teresa Esposito
  • AML cell study offers clues to super-drug improvement
  • Off-target effects dash gene editing hopes
  • Genetics of Xga blood group system uncovered
  • Urine test useful for monoclonal gammopathy
  • A message from BSH President, Professor Cheng-Hock Toh
  • BSH President Professor Cheng-Hock Toh elected as Academic Vice President of the RCP
  • Blood cancers taking longer to be diagnosed than other cancers
  • Study informs on monosomy 7 genetics
  • Fertility risk for sickle cell and chemotherapy patients
  • Knife crime surge draws on blood stocks
  • Urgent appeal for Ro blood donors
  • BSH expanding Early Stage Research Start-Up programme
  • Leukaemia patients spared repeat chemotherapy following NHS review
  • Shot Report 2017 published
  • Obituary - Dr S. Mitchell Lewis
  • Former BSH President Dr Victor Hoffbrand receives Wallace H. Coulter Award for Lifetime Achievement in Haematology
  • Computational platform developed for multiple myeloma treatment
  • Simple blood test could detect Multiple Myeloma
  • Novel targets for mixed lineage leukaemia
  • Patients perplexed by blood cancer diagnosis
  • Brexit blood product plans revealed
  • Tributes to campaigner who became nurse
  • Blood cancer patients could be denied life-saving CAR-T therapy
  • A message from BSH President, Professor Cheng-Hock Toh - August 2018
  • Blood cancer awareness - Meet BSH Member Graham Collins
  • Celebrating NHS 70 and Haematology
  • Blood test predicts lymphoma therapy success
  • Enzymes may enable type O blood transformation
  • CAR-T backed for NHS
  • “Achilles’ heel” of anaplastic large-cell lymphoma identified
  • Study discovers ten times more haematopoietic stem cells than previously thought
  • Study reveals the impact on the brain of chemotherapy for acute lymphoblastic leukaemia
  • Comment: Dr Maria Esposito on NHS decision to approve use of CAR T therapy
  • AI to improve platelet supply
  • Genomics focus: Meet BSH Member David Rees
  • European collaboration for cancer research
  • CAR-T therapy provisionally rejected for adult B-cell lymphoma
  • Office Closure & Temporary Office Move
  • ASM 2019: Call for abstract reviewers
  • Changes to BSH Membership from 2019
  • Immediate compression may reduce risk of long-term DVT complications
  • A message from BSH President, Professor Cheng-Hock Toh - September 2018
  • Paediatric radiotherapy guidance updated for new technologies
  • Lung cancer drugs studied for leukaemia treatment
  • BSH Student Essay Prize 2018
  • Inquiry searches for undiagnosed blood contamination victims
  • Apply for the 2019 Healthcare Science Awards
  • Dan's Story: BSH member inspires patient to follow career in medicine
  • CAR-T deal allows adult lymphoma treatment
  • May’s SOS for cancer care
  • Leukaemia UK launch 'Future of Haematology' Grants Programme
  • Hope for fewer blood transfusions for myelodysplasia care
  • World Thrombosis Day 2018 - Message from BSH President Professor Cheng-Hock Toh
  • World Thrombosis Day: Meet BSH Member & Thrombosis expert Professor Beverley Hunt
  • World Thrombosis Day: Thrombosis UK offer range of resources, grants and educational opportunities
  • New prognostic tool provides “step change” in myeloproliferative neoplasm care
  • Blood and organ donors from black communities needed
  • Genetics-based prognostic tool developed for myelodysplastic syndrome
  • NIHR-BSH Researcher of the Year Award scheme 2019
  • Massive new AML dataset published
  • BSH & Wiley renew partnership to publish British Journal of Haematology
  • New technique revealed to help blood cells regenerate
  • A message from BSH President, Professor Cheng-Hock Toh - October 2018
  • Duvelisib hope for hard-to-treat CLL and SLL
  • BSH Crucible Prize: Feature with 2018 winner Dr Sonia Wolf
  • ‘Rethink’ needed for classification of VTE
  • Relapsed AML returns in ‘stealth mode’
  • National Pathology Week - Meet BSH Member Dr Sheila O'Connor
  • Low-fat diet might benefit obese children with ALL
  • Denosumab effective for osteoporosis in transfusion-dependent thalassaemia
  • Chemotherapy and immunotherapy success in AML study
  • Top 10 research priorities for living with and beyond cancer announced
  • AML gene study brings personalised medicine one step closer
  • Discount deal makes CAR-T available to young leukaemia patients
  • Multiple myeloma drug hope
  • A message from BSH President, Professor Cheng-Hock Toh - November 2018
  • ‘Universal plasma’ filtration plans unveiled
  • SCID study identifies factors influencing survival
  • BSH to offer EHA Travel Grants
  • CRISPR therapy feasible for foetal haemoglobin reactivation
  • BSH Communications Committee Vacancy
  • Fred Hutchinson researchers present latest on CAR-T cell therapy at ASH 2018
  • Chance discovery could revolutionise platelet donations
  • Paediatric CAR-T therapy begins in England
  • BSH President Professor Cheng Hock Toh pays tribute to outgoing Editor of BJHaem, Professor Finbarr Cotter
  • Sickle cell gene therapy success
  • New tool to identify aggressive lymphomas
  • Differences between paediatric and adult AML uncovered
  • CAR T-cell therapy approved for more NHS treatment
  • CRISPR accuracy breakthrough
  • A message from BSH President, Professor Cheng-Hock Toh - December 2018
  • Obituary - Professor Sir David Weatherall
  • Lenalidomide extends remission in newly-diagnosed myeloma
  • Eye drop treatment offers AML hope
  • Human skin cells turned into blood stem cells
  • First European CAR T cell meeting announced
  • Boosted cord blood aids transplant
  • Haematology Nursing: Meet BSH Member Bethan Ingram
  • AZD8055 promise for CLL combination treatment
  • Comments needed for ASH VTE Guideline Treatment of Acute VTE
  • NHS plan offers new hope for blood cancer care
  • Blood screening for Zika ‘not cost‑effective’
  • CRISPR gene editing library identifies new immune regulators
  • Infected Blood Inquiry
  • Venetoclax fast-tracked into NHS for CLL
  • Ibrutinib effective for CLL therapy
  • New genetic classification of B-ALL
  • ‘Twin genes’ behind B-cell disease are not identical
  • World Thrombosis Day Campaign Appoints BSH member Beverley Hunt as New Steering Committee Chair
  • A message from BSH President, Professor Cheng-Hock Toh - January 2019
  • Delays in blood cancer diagnosis could be avoided, Yorkshire study finds
  • No benefit from transplantation in hypodiploid ALL for children and young people, study finds
  • Leukaemia causes bone marrow cells to age prematurely
  • NICE recommends new CAR-T cell therapy for DLBCL
  • BSH grant recipient has work published in Oncogene
  • Tissue homing of T cells revealed
  • Hope for new drugs for relapsed AML
  • CAR‑T therapy rejected for DLBCL in Scotland
  • Antibody could prepare for stem cell transplant
  • Sickle cell silent strokes studied
  • Obituary - Dr Bryon Roberts (1933 - 2019)
  • Vitamin D and immune cells stimulate myelofibrosis in MPN
  • BSH gathering UK Clinical Haematology Workforce data
  • BSH partnering with HVO to offer short term overseas placements for UK Haematologists
  • BSH and Wiley partner on a peer-reviewed open access journal
  • A message from BSH President, Professor Cheng-Hock Toh - February 2019
  • ‘Invisible’ stem cells offer new transplant prospects
  • Roger Counter Foundation to support BSH Research Grants
  • Role of free radicals in blood clotting revealed
  • Patient involvement partnership sets priorities for rare inherited anaemias
  • Thromboprophylaxis study shows limited benefits for cancer patients
  • Telomere test for CLL
  • International women's day 2019: Meet some of our women members making a difference in haematology
  • Second patient achieves full HIV remission after stem cell therapy
  • Vitamin analogue may boost stem cell transplant
  • AML cell type atlas created
  • Daratumumab combination therapy approved for relapsed multiple myeloma
  • Half-matched transplant success for sickle cell and thalassaemia
  • Two-minute test to assess platelet function developed
  • BSH Ordinary Trustee election results
  • Contradictory role for protein in AML uncovered
  • BSH Annual Scientific Meeting 2019 - Join the social media campaign
  • A message from BSH President, Professor Cheng-Hock Toh - March 2019
  • Chronic oncologist shortages revealed
  • New study reveals how mistakes in antibody production may trigger ALL
  • General Haem Task Force Vacancy
  • Deformable blood stem cells could help transplant procedures
  • Drug combination gives hope to older AML patients
  • Surprising role for protein in GvHD
  • Live imaging shows CAR-T therapy killing lymphoma cells
  • New sub groups of acute erythroid leukaemia defined
  • Gilteritinib improves FLT3-mutated AML survival
  • Successful gene therapy for SCID in infants
  • Cancer genetic vulnerabilities revealed on a large scale using CAS-9 knock out screens
  • Prophylactic Factor VIIa therapy tested for haemophilia
  • Old diabetes drug shows promise for preventing lymphoma
  • Professor Victor Hoffbrand receives BSH Lifetime Achievement Award
  • New promising target for AML discovered
  • Gene therapy may outperform stem cell transplant for beta-thalassaemia
  • Grant Impact report: Dr Yeong Jer Lim, ASH Travel Scholarship, 2018
  • High-risk multiple myeloma DNA marker identified
  • Grant Impact report: Dr George Adams, ASH Travel Scholarship, 2018
  • New study paves the way for B cell therapy
  • Single-cell analysis of bone marrow microenvironment cells completed
  • Spliceosome could hold key to stopping AML progression
  • ‘Powerful’ APL drug combination could benefit AML patients
  • New drug can tackle ibrutinib resistance in MCL patients
  • Experts call for SCD screening for migrants in Europe
  • New molecule driving Hodgkin’s lymphoma growth discovered
  • Grant Impact report: Katie Parrott, Student Elective Scholarship 2018
  • Genetic variations may affect sickle cell trait athletes’ risk of collapse
  • Meet Huw Rowswell - NIHR / BSH Nursing Award Winner
  • Lenolidomide approved by NICE for treatment of multiple myeloma
  • A message from BSH President, Professor Cheng-Hock Toh - May 2019
  • Neurotoxic side-effects of CAR T-cell therapy revealed
  • Wnt signalling study brings lab-made stem cells closer
  • New culture technique could increase access to stem cell transplants
  • New target for B-cell lymphoma identified
  • 'Antimicrobial resistance: Biting the hand that feeds' - Dr Jennifer Darlow wins Crucible Prize
  • New avenue for targeted therapy for T-cell leukaemia
  • Measuring walking speed aids prognosis of elderly cancer patients
  • Triple therapy boosts B-cell lymphoma treatment
  • New haemophilia gene therapy to help young patients
  • Grant Impact report: Thea Chandler, Student Elective Scholarship 2018
  • Grant Impact report: Eilish McKenna, Student Elective Scholarship 2018
  • Sickle Cell Disease in Childhood: Standards for Clinical Care Consultation
  • Pregnancy history of blood donors does not affect recipient mortality risk
  • World Sickle Cell Day 2019 - Dr Banu Kaya explains the advances made in the understanding and treatment of SCD
  • Hope for non-invasive prenatal sickle test
  • AML researcher receives Cancer Research UK fellowship grant
  • NHS prepares for new generation of ‘agnostic’ cancer drugs
  • Promising early results for novel sickle cell drug
  • BSH Global Haem SIG seeking Task Force volunteer for Plenary Speaker Scheme
  • Stress-responsive protein’s role in CML revealed
  • A message from BSH President, Professor Cheng-Hock Toh - June 2019
  • Myeloma leads the way in cancer survival improvements
  • Bleeding and thromboembolic risks for blood cancer patients estimated
  • Immunotherapy hope for paediatric ALL treatment
  • Dasatinib ‘pauses’ CAR T cell therapy activity
  • Depression linked to early death in blood cancer patients
  • Down's syndrome leukaemia genes pinpointed
  • Rise predicted in B-cell non-Hodgkin’s lymphoma cases
  • CAR-T cell therapy ‘super-charged’ for solid tumours
  • Cure Leukaemia Announce 12 Funded Centres Across The UK
  • Rise expected in haemophilia A and B market
  • Leukaemia stem cell study reveals cause of immune evasion
  • Effects of iron status on health studied
  • Physician Associate Focus - Meet BSH Member Jamie Saunders
  • BRCA2 mutations linked to childhood lymphoma
  • A message from BSH President, Professor Cheng-Hock Toh - July 2019
  • Antibiotics could be used to treat CTCL
  • New drug target identified for primary effusion lymphoma
  • Combination therapy shows early success in CLL trial
  • BSH/NHSE Acute Oncology Services Survey
  • Hope for new lymphoma ‘immunotransplant’ therapy approach
  • Mature AML cells can regain stem cell properties
  • Combination therapy for treatment-resistant ALL studied
  • Newly launched Haematology Podcast sees early success
  • Link between anaemia and necrotising enterocolitis studied
  • Guidelines Session ASM videos available for viewing
  • BSH seeks Consultant to join Communications Committee
  • New gene editing technique tested in lymphoma cells
  • Global Haematology SIG London Workshop
  • BSH seeks volunteer Chair for Genomics Working Group
  • NIHR-BSH Researcher of the Year Award
  • Access to haemophilia drug emicizumab widened
  • A message from BSH President, Professor Cheng-Hock Toh - August 2019
  • BSH Rebuttal to NICE NG89 Recommendations
  • Selinexor shows promise for refractory multiple myeloma
  • Red blood cell line may revolutionise malaria research
  • AML drug may be key to cancer immunotherapy
  • Heart risk after childhood cancer studied
  • New guidelines on rare aggressive T-PLL
  • Concern about blood cancer diagnosis progress
  • Use of haematopoietic stem cell transplantation for sickle cell disease for adults.
  • NHS England Evidence review: Comments needed on for delayed haemolytic transfusion reactions and hyperhaemolysis in patients with haemoglobinopathies
  • Three times more men with haemophilia than previously thought
  • Genomics Focus: Meet Dr Suthesh Sivapalaratnam
  • New potential targets for lymphoma treatment discovered
  • Radiotherapy could help prevent CAR-T cell therapy side effects
  • Scientists discover how lymphoma cells metastasise to the CNS
  • Arthritis drug could reduce MPN symptoms
  • Gene test reveals new option for JMML
  • A message from BSH President, Professor Cheng-Hock Toh - September 2019
  • Familial risk of blood cancers analysed
  • BSH Global Haematology SIG: We are looking for a Lab Scientist and Paediatric Haematologist for one week trip to Zambia
  • Laser technology cuts blood incubation time
  • Few sickle cell trials cross borders
  • New combination treatment suggested for AML
  • Hypertension warning for ibrutinib
  • Research starts on preventing cognitive decline in paediatric ALL patients
  • Debate rages over human germline editing
  • Studies highlight RNA splicing faults in cancer formation
  • Viagra potential for bone marrow mobilisation
  • Charity calls for an end to delays in blood cancer diagnosis
  • Collaboration to boost care of childhood cancer in developing world
  • Professor Andrew M. Evens appointed as Editor-in-Chief of British Society for Haematology (BSH)’s new Open Access journal eJHaem
  • Link between cognitive problems and fitness for ALL survivors
  • Improvements to cancer immunotherapy unveiled
  • Plant compound could improve gene therapy
  • ‘Prime editing’ system could efficiently correct DNA in human cells
  • A message from BSH President, Professor Cheng-Hock Toh - October 2019
  • Board of Trustee Nominations
  • Hospital visit patterns could identify potential myeloma risk
  • Treating ‘smouldering’ multiple myeloma delays progression
  • Trial reduces central nervous system relapse in ALL
  • New wave of embryonic haematopoiesis discovered
  • Antibiotics could overcome venetoclax resistance in AML
  • CRISPR-edited immune cells for cancer tested in Phase I trial
  • ASH-BSH Abstract Achievement Award winners announced
  • BSH President's November message
  • Immunotherapy study identifies multiple myeloma neoantigens
  • Hydroxyurea may prevent cytarabine resistance in AML
  • Bone marrow transplant survival rate rises
  • Progress for Philadelphia chromosome ALL treatment
  • Join the Teenage and Young Adult Special Interest Group
  • A look at the complexities and challenges in Lymphoma and the work of the BSH Lymphoma SIG on World Cancer Day Feb 4th 2020
  • Cutaneous T-cell lymphoma origins revealed
  • Defect drives primary resistance to CAR-T cell therapy
  • Gene therapy success for X-CGD patients
  • International Day of Women & Girls in Science 2020: An Interview with Professor Adele Fielding
  • Single gene cluster loss associated with multiple myeloma
  • Aplastic Anaemia Awareness Day 2020
  • Blood Clot Awareness Month 2020: Blood Clot Management at University Hospitals Plymouth
  • International Women’s Day 2020 – Interview with Dr. Tamara Everington
  • COVID-19 Updates
  • BSH cancels 2020 Annual Scientific Meeting
  • Charity issues coronavirus guidance for blood cancer patients
  • Genes identify ‘ultra-high risk’ multiple myeloma
  • BSH and COVID-19
  • NIHR Appoints Dr Dan Hart as National Specialty Lead for Haematology
  • Professor Toh's 24th and final message to BSH: #bettertogether
  • Announcement of new trustees
  • Introducing Professor Adele Fielding - BSH Presidents first message
  • COVID 19 causes new clotting disorder – Dublin study
  • NHSBT - Understanding the convalescent plasma trials for COVID-19
  • A message from BSH President, Professor Adele Fielding - May 2020
  • Novel AML model offers new target
  • Child shielding rules relaxed - but not for some blood cancer patients
  • Obituary - Professor Dennis Wright
  • Trial results support use of early prophylaxis for childhood haemophilia A
  • A message from BSH President, Professor Adele Fielding - June 2020
  • Immune landscape of haematological cancers mapped
  • A message from BSH President, Professor Adele Fielding - July 2020
  • BSH Member Research – we need your help
  • A message from BSH President, Professor Adele Fielding - August 2020
  • Medical marijuana for sickle cell patients means fewer hospitalisations
  • Guidelines on the use of irradiated blood components published on 18 August 2020
  • Blood transfusions could protect brain after stroke
  • A message from BSH President, Professor Adele Fielding - September 2020
  • Leukaemia nervous system “sanctuary” discovered
  • What is a virtual poster walk?
  • A message from BSH President, Professor Adele Fielding - October 2020
  • Blood group linked to COVID-19 risk
  • India trial finds limited effectiveness from convalescent plasma
  • New way to test drugs for children’s cancers
  • BSH Crucible Prize: Interview with 2020 winner Dr Joshua Bomsztyk
  • Board of Trustee Nominations 2020
  • A message from BSH President, Professor Adele Fielding - November 2020
  • Transplant proves beneficial for older myelodysplastic syndrome patients
  • No increased COVID-19 risk for children with cancer
  • COVID-19 thrombosis clarity to improve research
  • A message from BSH President, Professor Adele Fielding - December 2020
  • Myeloproliferative neoplasm mutations can occur decades before cancer develops
  • No benefit from increased haemoglobin threshold for very premature babies
  • Cord stem cell hope for severe COVID-19
  • On-off 'switches' to control CAR-T cell activity
  • Variation in cancer patient COVID-19 responses
  • New global clinical guidelines for von Willebrand Disease
  • Scientists identify possible therapeutic approach to overcome AML drug resistance
  • COVID-19 convalescent plasma collection halted after fresh setback
  • A message from BSH President, Professor Adele Fielding - January 2021
  • A message from BSH President, Professor Adele Fielding - February 2021
  • A message from BSH President, Professor Adele Fielding - March 2021
  • Cancer patients may need rapid COVID-19 vaccine booster, early study suggests
  • Single-cell genetic testing method identifies cancer stem cells
  • Whole genome sequencing role in guiding blood cancer treatment
  • Mechanism shared by sickle cell disease and malaria resistance revealed
  • Guidance produced by the Expert Haematology Panel (EHP) focussed on Vaccine induced Thrombosis and Thrombocytopenia (VITT)
  • Promising dual CAR-T therapy for B-cell lymphoma
  • New group launched to fund research into Covid-19 vaccine efficacy for blood cancer
  • A message from BSH President, Professor Adele Fielding - April 2021
  • Group of charities announce first blood cancer vaccine efficacy research funding
  • Charity collaborative announces investment of £800K in vaccine efficacy research
  • Keeping patients with leukaemia safe during the pandemic
  • Lockdown ending poses multiple risks for blood cancer patients
  • In memoriam Professor Amit Patel
  • Automated blood disease diagnosis moves closer
  • Study begins on rare blood clotting after COVID vaccines
  • Bone marrow DNA sequencing could help predict leukaemia relapse
  • Gene mutation linked to chemotherapy failure in lymphoma
  • Malaria parasite variants and sickle haemoglobin link discovered
  • Statistical model developed to predict outcomes for non-intensive AML therapy
  • Locally-manufactured CAR-T therapy effective for B-cell malignancies
  • Blocking both TNF and IL-6 may prevent GVHD
  • Moderate immune response effective against leukaemia
  • Cord blood transplant effective for non-remission AML
  • DNA discovery in B cell lymphoma development
  • Vulnerability found in metabolism of lymphoma cells
  • PARP inhibitors could treat blood cancers with gene defect
  • Rise in survival rate for relapsed Philadelphia-positive ALL
  • Blood changes could be responsible for COVID-19 patients’ cardiac thrombosis
  • Direct oral anticoagulants should be ‘standard-of-care’ for cancer patients with thrombosis
  • Blood cancer mutations identified decades before symptoms
  • Prolonged television viewing linked to blood clots
  • Where is the love? BSH President's January Message
  • Improved cancer treatment hope after two new discoveries
  • Mixed findings for convalescent plasma for COVID-19
  • CAR T cells persist for at least 10 years
  • ICU COVID patients’ bleeding risk from full-dose anticoagulants
  • Myeloma survival rates have increased
  • BSH Board of Trustee elections are now open
  • Drug may prevent gene-driven childhood ALL
  • EBMT and EHA release open access CAR-T handbook
  • Improved MRD monitoring of acute leukaemia
  • BSH supports Strengthening workforce planning in the health and care bill: coalition principles
  • Aberrant platelet activation triggers cerebral venous thrombosis
  • Mutation in childhood AML could define a new subtype
  • Transfusion risks for newborns on ECMO
  • Do you really want to hurt me? BSH President's February message
  • Pre-stem cell transplant chemotherapy affects brain regeneration
  • First sickle cell patients receive “life-changing” new drug on NHS
  • Small cerebral clot risk from Oxford AstraZeneca COVID jab
  • Gene therapy success for thalassemia patients
  • Targeting energy balance could be potential treatment for AML
  • Immunocompromised patients should have additional COVID-19 vaccine doses
  • Election results 2022
  • BSH's response to the conflict in Ukraine
  • Higher rates of clonal haematopoiesis found in World Trade Center first-responders
  • Stem cell groups found that drive MDS resistance
  • Study reveals new insights into lethal infant leukaemia
  • Paediatric patient care tailored through tumour genomic sequencing
  • Absence of donor bone marrow triggers Ukraine paediatric centre evacuation
  • Daratumumab approved for myeloma on NHS
  • The End - BSH President's March message
  • New pathogenic mechanism in MDS and AML identified
  • Backing for device to improve sickle cell care in England
  • BSH Crucible Prize: Interview with 2022 winner Dr Richard Buka
  • New target and potential treatment for AML identified
  • Implant can generate CAR-T cells in body to attack lymphoma
  • Study reveals cause of immunodeficiency in one identical twin
  • Role of extracellular vesicles in lymphoma revealed
  • BSH Presidential Message - Introductory message from President Josh Wright
  • Blood clot risk up to six months after COVID-19
  • New genetic vulnerability identified for adult T-cell leukaemia/lymphoma
  • Metabolism variations in AML identified
  • Immune system plays greater role in T-cell leukaemia than previously thought
  • Increase in breakthrough Omicron infections among blood cancer patients
  • Non-O blood types increase clot risk in cancer patients
  • Rewiring leukaemia cells can reverse drug resistance
  • Student training centre speeds up blood cancer diagnosis
  • Oncoprotein discovery could open up treatments for AML
  • Treatment hope for arterial thrombosis
  • Corticosteroid risk for sickle cell disease patients
  • CAR-T therapy hope for AML
  • Single-cell atlas of lymphoma stroma published
  • Zero-gravity study into blood flow and clot formation
  • New drive to develop myeloma screening
  • Long COVID patients’ exercise capacity linked to abnormal blood clotting
  • Genome sequencing reveals clues to CAR-T therapy resistance
  • Awards and Prizes
  • Terms & Conditions
  • Contact Us
  • Website FAQs
  • Articles of Association, Regulation and Signed Accounts
  • Get involved
  • Membership Terms and Conditions
  • Work for us
  • Room Hire
  • Apply for a Committee or SIG vacancy
  • Education
  • Haematology images
  • Bone Marrow Transplantation
  • Haemolytic-uraemic syndrome after stem cell transplantation
  • General Haematology
  • Atypical lymphocyte in primary HIV infection
  • Trephine biopsy in malignant melanoma
  • Bone marrow aspirate in malignant melanoma
  • Platelet aggregates, blood film
  • Oxalosis, trephine biopsy section
  • Intra-pelvic haemorrhage following trephine biopsy: CT scan of pelvis
  • Paroxysmal nocturnal haemoglobinuria associated with haemophagocytic syndrome
  • Gelatinous transformation
  • Jordans' anomaly
  • Cobra like macrophage in visceral leishmaniasis
  • Bacilli in blood film
  • Bacilli in blood film in pseudomonas septicemia
  • Multiple mitochondria in normal and tumour cells
  • Congenital Pelger–Huët anomaly
  • Oral haematoma
  • Histoplasma in peripheral blood neutrophil
  • Burkitt-like cytology in biphenotypic acute leukaemia
  • Burkitt-like cytology in biphenotypic acute leukaemia (1)
  • Extreme neutrophil vacuolisation in sepsis
  • Striking monocyte vacuolisation in sepsis
  • Toxic granulation and striking vacuolisation of neutrophils in sepsis
  • Intramonocytic malarial pigment
  • Histoplasmosis in bone marrow
  • Mycobacterium avium intracellulare infection in a patient with AIDS
  • Mycobacterium avium intracellulare (MAI) on routine H&E stain of a bone marrow section from a patient with AIDS
  • Diagnosis of systemic lupus erythematosus by bone marrow cytology
  • LE cells in incubated bone marrow
  • SLE diagnosed from bone marrow
  • Metastatic malignant melanoma in bone marrow, MGG stain
  • Metastatic malignant melanoma in bone marrow trephine biopsy section, immunohistochemistry, APAAP technique, with hmb45
  • Toxic Granuation and Döhle bodies in a patient with severe bacterial infection
  • Bone marrow sarcoidosis in a patient with diffuse large B-cell lymphoma
  • Visceral leishmaniasis (2)
  • Visceral leishmaniasis (3)
  • Letterer-Siwe disease (1)
  • Letterer-Siwe disease (2)
  • Letterer-Siwe disease (3)
  • Letterer-Siwe disease (4)
  • Alveolar rhabdomyosarcoma infiltrating the bone marrow
  • Bone marrow aspirate in Niemann-Pick disease
  • Leishmaniasis
  • Haemophagocytosis in probable typhoid fever (1)
  • Haemophagocytosis in probable typhoid fever (2)
  • Haemophagocytosis in probable typhoid fever (3)
  • Haemophagocytosis in probable typhoid fever
  • Probable granuloma in typhoid fever (1)
  • Probable granuloma in typhoid fever (2)
  • Döhle bodies and toxic granulation
  • Endothelial cells, low power
  • Endothelial cells, high power
  • Binucleated lymphocytes
  • Cytoplasmic fragments mistaken for malaria parasites (1)
  • Cytoplasmic fragments mistaken for malaria parasites (2)
  • Cytoplasmic fragments mistaken for malaria parasites (3)
  • Haemosiderin in a plasma cell, May-Grünwald-Giemsa stain
  • Tuberculous granulomas in a trephine biopsy section, low power
  • Tuberculous granulomas in a trephine biopsy section, low power (ii)
  • Tuberculous granulomas in a trephine biopsy section, high power
  • Toxic granulation and left shift induced by G-CSF
  • Nuclear dysplasia and Döhle body formation induced by G-CSF
  • Neutrophil vacuolation induced by G-CSF
  • Multiple Döhle bodies and nuclear dysplasia induced by G-CSF
  • Döhle body and vacuolation induced by G-CSF
  • Left shift, toxic granulation, Döhle bodies and nuclear dysplasia induced by G-CSF
  • Dysplastic neutrophil with ring-shaped nucleus following G-CSF therapy
  • Alder-Reilly anomaly in a neutrophil
  • Alder-Reilly anomaly in two neutrophils
  • Gasser cell (lymphocyte with heavy granules)
  • Monocyte with heavy granules and vacuoles as the result of a mucopolysaccharidosis
  • Neutrophil showing Alder-Reilly anomaly
  • Lymphocyte in mucopolysaccharidosis
  • Monocyte in mucopolysaccharidosis
  • Carcinoma cells infiltrating bone marrow with reactive fibrosis
  • Carcinoma cells infiltrating bone marrow (2) with reactive fibrosis
  • Carcinoma cells in an imprint from a trephine biopsy section, low power
  • Carcinoma cells in an imprint from a trephine biopsy section, high power
  • PAS-block positivity suspected from a Romonowsky-stained film
  • Buffy coat film showing a clump of carcinoma cells
  • Sea-blue histiocyte
  • Sea-blue histiocytes
  • Melanonychia striata secondary to hydroxycarbamide
  • Chemotherapy-induced dysplasia
  • Leishman-Donovan bodies in the bone marrow
  • Leishmaniasis (1)
  • Cohesive epithelioid macrophages in a bone marrow aspirate indicating the presence of granulomas (low power)
  • Cohesive epithelioid macrophages in a bone marrow aspirate indicating the presence of granulomas (high power)
  • Histology of bone marrow granuloma, H& E, low power
  • Histology of bone marrow granuloma, H& E, high power
  • Erythroid island
  • A Mott cell
  • Haemophagocytosis in the bone marrow aspirate of a young woman with coeliac disease
  • Gaucher disease discovered during pregnancy
  • Normal bone marrow film, Jenner-Giemsa with phosphate buffer at pH 6.6
  • Infection-related haemophagocytic lymphohistiocytosis (HLH) in a HIV stage 4 patient with Mycobacterium tuberculosis infection
  • Neuroblastoma with neuropil
  • Emperipolesis in a patient with RAEB-2
  • Dural biopsy in extranodal Rosai-Dorfman disease, which radiologically and histologically mimicked meningioma (H& E)
  • Dural biopsy in extranodal Rosai-Dorfman disease, which radiologically and histologically mimicked meningioma (immunohistochemistry for S-100)
  • Fragmentation haemolysis secondary to sepsis in a three-month-old female infant
  • Plasmacytoid lymphocyte (Tϋrk cell)
  • Congenital hip dislocation in Fanconi anaemia, X-ray
  • Howell-Jolly body-like neutrophil inclusion (1)
  • Howell-Jolly body-like neutrophil inclusion (2)
  • Monocytes ‒ yes, but monotony ‒ never!
  • Haemophagocytic lymphohistiocytosis
  • Reactive myelofibrosis in metastatic tumour of unknown origin
  • Reactive myelofibrosis (reticulin stain) in a metastatic tumour of unknown origin
  • Plasmodium falciparum gametocyte (i)
  • Plasmodium falciparum gametocyte (ii)
  • Reactive haemophagocytosis in a bone marrow aspirate
  • The stages of mitosis
  • Haemoglobin H disease
  • Bone marrow metastatic involvement by penile squamous cell carcinoma
  • Crystal-storing histiocytosis associated with plasma cell myeloma
  • Neutrophils changed appearance with a new heart
  • LD bodies with marrow plasmacytosis
  • Tadpole in the marrow
  • Large granular lymphocyte, blood film
  • Perls' stain showing iron in macrophages
  • Erythroid island with central macrophage
  • Reactive lymphocytes in infection by Brucella spp (Brucellosis, also called undulant fever, or Malta fever)
  • Disseminated metastatic prostatic carcinoma in a young male (1)
  • Histoplasma in peripheral blood and bone marrow
  • Howell-Jolly body-like inclusions in reactive myelocytes and metamyelocytes
  • Non-immune haemolytic anaemia in a severe burns patient
  • Mycobacterium avium intracellulare on bone marrow trephine
  • Cryptococcus neoformans: Cerebrospinal fluid (CSF) cytospin and bone marrow trephine
  • Prostatic adenocarcinoma metastasis in bone marrow (H&E stain)
  • Immunobiology
  • Lymphoid Malignancy
  • Simultaneous diagnosis of precursor B-cell acute lymphoblastic leukaemia and chronic lymphocytic leukaemia, high power
  • Neurolymphomatosis
  • Anaplastic large cell lymphoma lymphoma
  • Multiple myeloma 2, giant cell
  • Syncytial neoplastic cells in paediatric Hodgkin lymphoma
  • Hodgkin lymphoma in the bone marrow, trephine biopsy section, H& E, low power
  • Hodgkin lymphoma in the bone marrow, trephine biopsy section, immunohistochemistry for CD30, low power
  • Hodgkin lymphoma in the bone marrow, trephine biopsy section, H& E, high power, 1
  • Hodgkin lymphoma in the bone marrow, trephine biopsy section, H& E, high power, 2
  • Classical Reed-Sternberg cell in film of fine needle aspirate (Jenner-Giemsa stain)
  • Lymph node biopsy in Hodgkin lymphoma
  • Immunohistochemistry in Hodgkin's disease (Hodgkin lymphoma)
  • Blood film of mantle cell lymphoma in evolution
  • Paratrabecular infiltration in follicular lymphoma
  • Diffuse large B-cell lymphoma
  • Finger necrosis in cold agglutinin disease
  • Type 1 cryoglobulinaemia in a patient with low grade non-Hodgkin lymphoma
  • Rouleaux formation in lymphoplasmacytic lymphoma
  • Splenic marginal zone lymphoma with peripheral blood lymphocyte clusters
  • Diffuse large B-cell lymphoma in leukaemic phase
  • Comparison of Ki67 positivity in mantle cell lymphoma (left) and in blastoid transformation (right)
  • FDG-PET scan in cutaneous blastoid mantle cell lymphoma showing intense activity in a subcutaneous nodule
  • Cold agglutinin in non-Hodgkin lymphoma
  • Follicular lymphoma in leukaemic phase
  • Marginal zone lymphoma of bone: MRI appearance
  • Marginal zone lymphoma of bone: histology
  • Marginal zone lymphoma of bone: immunohistochemistry
  • PET/CT showing neurolymphomatosis as the presenting feature in a relapsed diffuse large B-cell lymphoma
  • Bone marrow aspirate in primary diffuse large B-cell lymphoma of bone marrow (i)
  • Bone marrow aspirate in primary bone marrow diffuse large B-cell lymphoma (ii)
  • Hairy cell leukaemia
  • Anaplastic large cell lymphoma, ALK-positive, in pleural fluid
  • Ziehl-Neelsen (ZN) stain demonstrating acid-fast bacilli, identified as M. chelonae, which were the cause of vascular-catheter-related bacteraemia
  • Anaplastic large T-cell lymphoma
  • Primary cutaneous T-cell non-Hodgkin lymphoma on the shin completely healed following radiotherapy
  • Skin infiltration in patient with adult T-cell leukaemia/lymphoma
  • Primary cutaneous ALK-negative anaplastic large T-cell lymphoma
  • Blood film in adult T-cell leukaemia/lymphoma
  • Immunohistochemistry in subcutaneous panniculitis-like T-cell lymphoma
  • Sézary cells
  • Anaplastic large cell lymphoma overspill into peripheral blood
  • Leukaemic phase of extranodal NK/T cell lymphoma of nasal type, peripheral blood film
  • Anaplastic large cell lymphoma
  • Peripheral blood in T-prolymphocytic leukaemia
  • Hyperpigmentation and nodularity of skin in POEMS syndrome
  • Circulating myeloma cell in a patient with refractory multiple myeloma
  • Extramedullary myeloma
  • Multiple myeloma cells in cerebrospinal fluid
  • Extramedullary plasmacytoma of lung, haematoxylin and eosin
  • Flaming plasma cell in IgA myeloma
  • Pathological fracture of the proximal third of the shaft of the left humerus in multiple myeloma
  • Cryoglobulinaemia
  • CT scan of the pelvis in amyloidosis
  • Plasmacytoma of the orbit in multiple myeloma, MRI scan (2)
  • Plasmacytoma of orbit, histology following orbital biopsy: left, hematoxylin and eosin; right, immunohistochemistry for CD38
  • Histology and immunohistochemistry of unusual skin lesions in multiple myeloma
  • Bone marrow in multiple myeloma (1)
  • Bone marrow in multiple myeloma (4): unusual cytoplasmic inclusions in myeloma cells
  • Bone marrow in multiple myeloma (5): unusual cytoplasmic inclusions in myeloma cells
  • Myeloma cells with crystals (i)
  • Myeloma cells with crystals (ii)
  • Myeloma cells with crystals (iii)
  • Auer-rod like crystals in macrophages in myeloma (i)
  • Auer rod-like crystals in macrophages in multiple myeloma (ii)
  • Extramedullary plasmacytoma of the sphenoid sinus: T2 weighted MRI image
  • Phagocytosis by myeloma cells
  • Circulating plasma cells and rouleaux in plasma cell leukaemia
  • Plasmablast in plasma cell leukaemia
  • Auer-rod like inclusions in multiple myeloma
  • Myeloma cells including a trinucleated cell containing Auer-rod-like inclusions
  • Tissue biopsy section, multiple myeloma, haematoxylin and eosin
  • Giant myeloma cells
  • Giant binucleate myeloma cell
  • Giant trinucleate myeloma cell
  • Giant quadranucleate myeloma cell
  • Neoplastic pleural effusion in refractory multiple myeloma
  • Intracranial plasmacytoma causing bilateral sixth nerve palsy (1)
  • Intracranial plasmacytoma causing bilateral sixth nerve palsy (2)
  • Multinucleated tumour cell in multiple myeloma
  • Multinucleated cell in multiple myeloma
  • Multinucleated plasma cell in multiple myeloma
  • Giant multinucleated tumour cells in multiple myeloma
  • A giant multinucleated tumour cell in multiple myeloma
  • Rouleaux formation and plasma cell - peripheral blood film of a patient with multiple myeloma
  • Plasma cells in multiple myeloma - peripheral blood film
  • Multiple myeloma 5, Dutcher body
  • Multiple myeloma (1)
  • Multiple myeloma (2)
  • Multiple myeloma (3)
  • Multiple myeloma (4)
  • Multiple myeloma (5)
  • Multiple Myeloma 1, Dutcher bodies
  • Blood film in chronic lymphocytic leukaemia, mixed cell type
  • CT scan showing a macronodular pattern of infiltration in chronic lymphocytic leukaemia
  • CLL and metastatic tumour
  • Aggressive NK cell leukaemia/lymphoma
  • Aggressive NK cell lymphoma
  • Flow cytometry in NK-lineage large granular lymphocytic leukaemia
  • Trephine biopsy in Hodgkin's disease
  • Bone marrow aspirate showing a Reed-Sternberg cell
  • Foamy macrophages in ALL
  • A typical basket-shaped smear cell in acute lymphoblastic leukaemia
  • A small blast cell in the peripheral blood
  • Symptomatic osteonecrosis of the knee in a patient with Hodgkin lymphoma
  • Gross disfigurement secondary to extensive diffuse large B-cell lymphoma of the scalp
  • Hyperhaploid multiple myeloma: very rare high-risk genetic subtype
  • Intracardiac lymphoma on MRI imaging.
  • Russell bodies in bone marrow of patient with lymphoplasmacytic lymphoma (1)
  • Russell bodies in bone marrow of patient with lymphoplasmacytic lymphoma (2)
  • Bi-nuclear lymphocyte
  • AITL-RDD
  • T-ALL relapsing as AML: the same but different
  • Predominance of plasma cells
  • CAR-T cells found in CSF
  • Myeloid Malignancy
  • Chronic myelomonocytic leukaemia
  • Imatinib-induced myelodysplasia: clues in a peripheral blood film
  • Leukaemia cutis
  • Chronic myeloid leukaemia in accelerated phase
  • Chronic myeloid leukaemia in chronic phase
  • Hypopyon in blast crisis of chronic myelogenous leukaemia
  • CML - Hypolobated small megakaryocyte and a pseudo-Gaucher cell
  • Promyelocyte with a loose bundle of Auer rods acute promyelocytic leukaemia
  • The retina in acute myeloid leukaemia
  • Cytoplasmic RNP and basic protein content of blasts in AML
  • ATRA-induced scrotal ulcers
  • Fluorescence in situ hybridisation with ABL and RUNX1 probes (red) and ETV6 and BCR probes (green)
  • Peripheral blood film in AML with t(9;11)(p22;q23)
  • Blastic plasmacytoid dendritic cell neoplasm, clinical photograph
  • Blood film in acute megakaryoblastic leukaemia
  • Blood film in acute megakaryoblastic leukaemia (1)
  • Acute basophilic leukaemia, bone marrow aspirate
  • Clinical features of haematodermic CD4+CD56+ neoplasm (blastic plasmacytoid dendritic cell neoplasm)
  • Haemophagocytosis
  • Acute megakaryoblastic leukaemia, peripheral blood
  • Acute myeloid leukaemia, blood film
  • AML with Pseudo-Chédiak-Higashi granules
  • BM aspirate in acute promyelocytic leukaemia
  • Auer rods
  • PAS-positivity in acute erythroid leukaemia
  • Acute leukaemia with histiocytic differentiation (1)
  • Acute myeloid leukaemia with histiocytic differentiation (2)
  • Acute myeloid leukaemia with histiocytic differentiation (3)
  • Acute myeloid leukaemia with histocytic differentiation (4)
  • Acute myeloid leukaemia in a patient with b thalassaemia major, post-splenectomy (1)
  • Acute myeloid leukaemia in a patient with b thalassaemia major, post-splenectomy
  • Auer rods in a neutrophil following ATRA treatment of acute promyelocytic leukaemia (i)
  • Auer rod in a neutrophil in a patient with acute promyelocytic leukaemia treated with ATRA (ii)
  • Dysplastic neutrophil during ATRA treatment of acute promyelocytic leukaemia (i)
  • Dysplastic neutrophil during ATRA treatment of acute promyelocytic leukaemia (ii)
  • Unusually large granules in M1 AML (i)
  • Unusually large granules in M1 AML (ii)
  • Unusually large granules in M1 AML (iii)
  • Unusually large granules in M1 AML (iv)
  • Unusually large granules in M1 AML (v)
  • Unusually large granules in M1 AML (vi)
  • Unusually large granules in M1 AML (vii)
  • Unusually large granules in M1 AML (viii)
  • Peripheral blood film in acute monoblastic leukaemia (Jenner-Giemsa stain)
  • Bone marrow aspirate film in acute monoblastic leukaemia (Jenner-Giemsa stain)
  • Non-specific esterase (NSE) in acute monoblastic leukaemia (substrate: alpha naphthyl acetate esterase)
  • Extracellular Auer rods: Can this be another clue to a diagnosis of acute promyelocytic leukaemia?
  • Acute monocytic leukaemia with leukaemic cells resembling histiocytes (i)
  • Acute monocytic leukaemia with leukaemic cells resembling histiocytes (ii)
  • Acute monocytic leukaemia with leukaemic cells resembling histiocytes (iii); note long cytoplasmic tails of some cells
  • Acute monocytic leukaemia with leukaemic cells resembling histiocytes (iv); note that several cells have long cytoplasmic tails
  • Mitotic figure in a leukaemic cell in a patient with acute monocytic leukaemia with leukaemic cells resembling histiocytes (v)
  • Cytological/cytochemical diagnosis of the variant form of acute promyelocytic leukaemia
  • Morphological diagnosis of variant form of acute promyelocytic leukaemia, MGG (i)
  • Morphological diagnosis of variant form of acute promyelocytic leukaemia, MGG (ii)
  • Sudan black B stain in the variant form of acute promyelocytic leukaemia, SBB (i)
  • Sudan black B stain in the variant form of acute promyelocytic leukaemia, SBB (ii)
  • Sweet syndrome
  • Blood film of a four-day-old baby with Down syndrome and transient abnormal myelopoiesis showing blast cells
  • Blood film of a four-day-old baby with Down syndrome and transient abnormal myelopoiesis showing an immature cell of basophil lineage
  • Blood film of a four-day-old baby with Down syndrome and transient abnormal myelopoiesis showing a nucleated red blood cell and a blast cell
  • Dysplastic maturation during ATRA treatment of acute promyelocytic leukaemia
  • Acute basophilic leukaemia, bone marrow, toluidine blue stain
  • Acquired haemoglobin H disease
  • Circulating dysplastic megakaryocyte in Down syndrome
  • Hypolobulated megakaryocyte in 5q- syndrome
  • Myelodysplastic syndrome, nuclear abnormalities
  • Increased iron stores in refractory anaemia with excess of blasts
  • Hypolobated megakaryocytes in refractory anaemia with excess of blasts
  • Increased and dysplastic megakaryocytes in refractory anaemia with excess of blasts
  • Dysplastic megakaryocytes, blast cells and increased proerythroblasts in RAEB
  • A hypolobated megakaryocyte and immature cells, probably proerythroblasts, in a patient with RAEB
  • Disorganised marrow in RAEB with increased immature cells, probably blast cells as well as proerythroblasts
  • Myeloid neoplasm with FIP1L1-PDGFRA
  • Intravascular haematopoiesis
  • CT of chest showing extramedullary haemopoiesis
  • Juvenile myelomonocytic leukaemia in beta thalassaemia major, low power of peripheral blood film
  • Juvenile myelomonocytic leukaemia in beta thalassaemia major, high power view of blood film (1)
  • Juvenile myelomonocytic leukaemia in beta thalassaemia major, high power view of blood film (2)
  • Juvenile myelomonocytic leukaemia in beta thalassaemia major, high power view of blood film (3)
  • Splenic histology in a patient with advanced primary myelofibrosis
  • Essential thrombocythaemia - giant megakaryocyte
  • Systemic mastocytosis, bone marrow aspirate
  • Emperipolesis
  • Emperipolesis (1)
  • PB, primary myelofibrosis
  • Bone marrow trephine biopsy in primary myelofibrosis, low power
  • Bone marrow biopsy - Parrafin embedded section - Masson trichrome stain - PRIMARY MYELOFIBROSIS showing collagen fibrosis & osteomyelosclerosis
  • Neonatal Langerhans cell histiocytosis(LCH) showing reactive haemophagocytosis in the bone marrow aspirate
  • MYC overexpressing acute myeloid leukaemia with botryoid white cell nuclei as well as unusual cytoplasmic inclusions
  • Blastic plasmacytoid dendritic cell leukaemia
  • Acute promyelocytic leukaemia (APML) like morphology in acute myeloid leukaemis (AML) with myelodysplastic syndrome (MDS) related changes
  • Emperipolesis in megakaryocyte (1)
  • Marrow collagen fibrosis (MT stain) (1)
  • Marrow collagen fibrosis (VG stain) (1)
  • AML with t(8;21)
  • The Rods
  • AML with myelodysplasia-related changes
  • Faggot cells acute pro-myelocytic leukaemia
  • Bone marrow necrosis in acute leukemia
  • Therapy related AML with t(9;11) and KRAS mutation
  • Myeloid blast cells
  • Macrophage phagocytosis of atypical promyelocyte in acute promyelocytic leukemia.
  • Paediatrics
  • Blast cells in a neonate with Down's syndrome
  • Leukaemic hypopyon
  • A micromegakaryocyte in a child with refractory anaemia with excess of blasts-2 (RAEB2)
  • Rhabdomyoblasts in the peripheral blood in rhabdomyosarcoma
  • Hereditary xerocytosis, blood film
  • ABO haemolytic disease of the newborn (HDN)
  • Dystrophic nails in dyskeratosis congenita
  • Osteopetrosis, trephine biopsy section
  • Bilirubin crystals in neonatal hyperbilirubinaemia
  • Platelets and Haemostasis
  • Scurvy
  • Platelet satellitism
  • Normal platelet EM
  • Grey platelet syndrome EM
  • Intraretinal haemorrhage in autoimmune thrombocytopenic purpura
  • Submacular haemorrhage in autoimmune thrombocytopenic purpura
  • Macular retinal atrophy following submacular haemorrhage in autoimmune thrombocytopenic purpura
  • A cord-like fragment of megakaryocyte cytoplasm in the bone marrow of a patient with immune thrombocytopenia
  • Cord-like fragments of megakaryocyte cytoplasm in the bone marrow of a patient with immune thrombocytopenia
  • Haemarthroses
  • Knee showing haemarthrosis
  • Patient with acquired factor VIII deficiency
  • Suspected Bernard-Soulier syndrome, 4
  • Suspected Bernard-Soulier syndrome, 1
  • Suspected Bernard-Soulier syndrome, 2
  • Suspected Bernard-Soulier syndrome, 3
  • Osler-Weber-Rendu disease
  • Haemorrhagic diathesis in a bulimia nervosa patient
  • Haemophilic pseudocyst
  • Red Cell Disorders
  • Pyruvate kinase deficiency, post-splenectomy
  • Erythroid islands: the crèches for the baby erythroids!
  • An erythroid island
  • Stomatocytes
  • Sickle cell anaemia
  • Coexisting sickle cell anaemia and G6PD deficiency
  • Bone marrow fibrosis following bone marrow infarction in sickle cell anaemia
  • Compound heterozygosity for haemoglobin S and haemoglobin C, peripheral blood film
  • Compound heterozygosity for haemoglobin S and haemoglobin C, peripheral blood film, high power
  • Compound heterozygosity for haemoglobin S and haemoglobin C, peripheral blood film, high power (1)
  • Dyserythropoiesis in beta thalassaemia major
  • Erythroid hyperplasia, basophilic stippling and two erythroblasts containing alpha chain inclusions in beta thalassaemia major
  • Two alpha chain inclusions in an erythroblast in a patient with beta thalassaemia major
  • Dyserythropoiesis and an erythroblast containing an alpha chain inclusion in beta thalassaemia major
  • Hyperplastic erythropoiesis and a macrophage containing erythroblasts and cellular debris, a visual representation of ineffective erythropoiesis
  • Iron-laden macrophage in beta thalassaemia major; there is cellular debris and refractile brown haemosiderin within the macrophage
  • An erythroblast in beta thalassaemia major showing dyserythropoiesis (lobulated nucleus)
  • An erythroblast in beta thalassaemia major showing a paranuclear alpha chain inclusion and dyserythropoiesis (lobulated nucleus)
  • Two erythroblasts showing defective haemoglobinisation in beta thalassaemia major
  • Ineffective erythropoiesis in beta thalassaemia major; a macrophage contains phagocytosed erythroblasts and golden-brown haemosiderin
  • Haemoglobin H disease
  • Dyserythropoiesis and Howell-Jolly bodies in defectively haemoglobinised cells. Normal transfused cells are also present
  • Alpha chain inclusion in a circulating erythroblast
  • Alpha chain inclusion surrounded by basophilic stippling in a circulating erythroblast
  • Three erythroblasts containing alpha chain inclusions and small Howell-Jolly bodies
  • Alpha chain inclusions, Howell-Jolly bodies and basophilic stippling
  • Haemoglobin H inclusions
  • Haemoglobin H inclusions (1)
  • Acanthocytosis in abetalipoproteiaemia
  • Dehydrated variant of hereditary stomatocytosis
  • Haemoglobin H disease and G6PD deficiency (1)
  • Haemoglobin H disease and G6PD deficiency (2)
  • Haemoglobin H disease and G6PD deficiency (3)
  • Pyruvate kinase deficiency, post-splenectomy (2)
  • Pyruvate kinase deficiency, post-splenectomy (1)
  • Coexistence of G6PD deficiency and sickle cell anaemia
  • Combined vitamin B12 and folate deficiency
  • Combined B12 and folate deficiency
  • Marked hypochromia and microcytosis in severe iron deficiency anaemia
  • A micronormoblast in the circulation in severe iron deficiency anaemia
  • Elliptocytes (pencil cells) and marked hypochromia and microcytosis in severe iron deficiency anaemia
  • Haemolytic uraemic syndrome, peripheral blood film
  • Plasmodium malariae
  • Malaria in a patient with Southeast Asian ovalocytosis
  • Malaria in a patient with Southeast Asian ovalocytosis (1)
  • Cabot's ring
  • Microangiopathic haemolytic anaemia resulting from a viper bite
  • Lantern cells after kidney transplant
  • Lantern cells after kidney transplant 2
  • Lantern cells after kidney transplant 3
  • Asexual and sexual mature Plasmodium vivax sharing a red cell
  • HbH-like inclusions in congenital sideroblastic anaemia
  • Sickled red blood cells
  • Transfusion Medicine
  • Blood grouping, microtitre plate
  • Extravasation of transfused blood
  • Prostatic adenocarcinoma metastasis in Bone Marrow ( H&E stain ).
  • Other organisations
  • Students
  • Submit content
  • Lectures and Videos
  • Patient Perspective: The journey of Pain in Sickle Cell Disease
  • Conference and events
  • Events
  • 15th Annual Sickle Cell and Thalassaemia Conference (2)
  • Haematology in Obstetrics Course
  • Certificate of Advanced Studies in Antithrombotic Management
  • Haematology Clinical Science FRCPath Exam Preparation Study Half-Day
  • 4th BSH Return to Work Day
  • UCLH FRCPath Part 2 Haematology mock exam and revision course
  • ST3 Induction Day
  • ISTH 2022 Congress
  • 25th London Lymphoma Forum
  • Current Thinking in Haematological Malignancies (2)
  • Pathology Summer School 2022
  • The HMDS Annual Haematology Update Day
  • Haematology for the Workforce of the Future (1)
  • Cell Therapy at the Limits
  • BSBMTCT Scientific Showcase: Advanced Cellular Therapy
  • IHN- SHOT Symposium
  • BlooDHIT
  • Paediatric Haematology Study Day 2022 (1)
  • Annual Scientific Meeting
  • Promote your haematology event
  • Event Terms and Conditions
  • Crucible Prize
  • Event FAQs
  • Haematology for the Workforce of the Future 2022
  • Genomics
  • Genomics Videos
  • Genomics Resources
  • Demonstration Videos
  • Guidelines
  • Guidelines
  • Diagnosis and Management of Aplastic Anaemia
  • Diagnosis of B12 and Folate Deficiency
  • Diagnostic Pathway for the Investigation of Thrombocytosis
  • Investigation and Management of Adults and Children Presenting with Thrombocytosis
  • Laboratory Diagnosis of Functional Iron Deficiency
  • Laboratory Diagnosis of Malaria
  • Management of Acute Chest Syndrome in Sickle Cell Disease
  • Modification of Diagnostic Criteria for Essential Thrombocythaemia
  • Significant Haemoglobinopathies: Guidelines for Screening and Diagnosis
  • Use of JAK Inhibitors in the Management of Myelofibrosis
  • Use of Multicolour Flow Cytometry in the Diagnosis of Haematological Neoplasms
  • Diagnosis and Investigation of AL Amyloidosis
  • Diagnosis and Management of Acquired Coagulation Factor Inhibitor
  • Diagnosis and Management of Respiratory Viral Infections in Patients with Haematological Malignancy
  • Management of Diffuse Large B-cell Lymphoma
  • Haematological Malignancies and ITU
  • Investigation and Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma
  • Management of AL Amyloidosis
  • Management of AML in Pregnancy
  • Management of Tumour Lysis Syndrome in Adults and Children with Haematological Malignancies
  • Assessment of Bleeding Risk Prior to Surgery or Invasive Procedures
  • Cancer and Thrombosis
  • Diagnosis and Management of Heparin Induced Thrombocytopenia: Second Edition
  • Diagnosis and Management of Rare Coagulation Disorders
  • Diagnosis and Management of Thrombocytopenic Purpura and Other Thrombotic Microangiopathies
  • Diagnosis and Management of Von Willebrand Disease
  • Diagnosis and Treatment of Factor VIII and IX Inhibitors in Congenital Haemophilia
  • Fibrinogen Assays
  • Investigation and Management of Antiphospholipid Syndrome
  • Investigation and Management of Venous Thrombosis at Unusual Sites
  • Investigation, Management and Prevention of Venous Thrombosis in Children
  • Laboratory Investigation of Heritable Disorders of Platelet Function
  • Management of Bleeding in Patients on Antithrombotic Agents
  • Measurement of Non-Coumarin Anticoagulants and their Effects on Tests of Haemostasis
  • Oral Anticoagulation with Warfarin - 4th Edition
  • Patient self-testing and self-management of oral anti-coagulants with vitamin K antagonists
  • Testing for Heritable Thrombophilia
  • Travel-Related Venous Thrombosis
  • Use of Vena Cava Filters
  • Administration of Blood Components
  • Blood Grouping and Antibody Testing in Pregnancy
  • Clinical Use of Apheresis Procedures
  • Haematological Management of Major Haemorrhage
  • Identification and Management of Pre-Operative Anaemia
  • Investigation and Management of Acute Transfusion Reactions
  • Management of Anaemia and Red Cell Transfusion in Adult Critically Ill Patients
  • Policies on Alternatives to Allogeneic Blood Transfusion: Predeposit Autologous Blood Donation
  • Pre-Transfusion Compatibility Procedures in Blood Transfusion Laboratories
  • Specification, Implementation and Management of Information Technology (IT) Systems in Hospital Transfusion Laboratories
  • The Estimation of Fetomaternal Haemorrhage
  • Transfusion for Fetuses, Neonates and Older Children
  • Use of Anti-D Immunoglobin for the Prevention of Haemolytic Disease of the Fetus and Newborn
  • Use of Platelet Transfusions
  • Validation and Qualification, Including Change Control, for Hospital Transfusion Laboratories
  • Investigation and Management of Eosinophilia
  • The diagnosis and management of primary autoimmune haemolytic anaemia
  • Management of Drug-Induced Immune and Secondary Autoimmune Haemolytic Anaemia
  • Peri-Operative Management of Anticoagulation and Antiplatelet Therapy
  • Red Cell Transfusion in Sickle Cell Disease Part l
  • Red Cell Transfusion in Sickle Cell Disease Part II
  • Investigation of Newly Detected M-Proteins and the Management of MGUS
  • Diagnosis and Management of Disseminated Intravascular Coagulation (1)
  • Management of Thrombotic and Haemostatic issues in Paediatric Malignancy
  • Spectrum of fresh frozen plasma and cryoprecipitate products
  • Diagnosis and therapy of genetic haemochromatosis (review and 2017 update)
  • Investigation and management of a raised serum ferritin
  • Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease
  • Investigation and management of Transient Leukaemia of Down Syndrome
  • Good practice paper on the diagnosis and investigation of patients with mantle cell lymphoma
  • Guideline for the management of mantle cell lymphoma
  • The use of viscoelastic haemostatic assays in the management of major bleeding
  • Diagnosis and management of primary central nervous system diffuse large B‐cell lymphoma
  • Diagnosis and management of polycythaemia vera
  • Management of specific situations in polycythaemia vera and secondary erythrocytosis
  • The Prevention of glucocorticoid‐induced osteoporosis in patients with immune thrombocytopenia receiving steroids: Good Practice Paper
  • The management of primary mediastinal B‐cell lymphoma: Good Practice Paper
  • Point of Care in General Haematology
  • UK guidelines on the management of iron deficiency in pregnancy
  • Laboratory diagnosis of G6PD deficiency
  • Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline (ICTM Collaboration)
  • The use of prophylactic factor replacement for children and adults with Haemophilia A and B
  • Guideline on Laboratory aspects of assays used in haemostasis and thrombosis
  • GPP The prevention of central nervous system relapse in diffuse large B‐cell lymphoma
  • Guideline on the investigation and management of follicular lymphoma
  • Guideline on the diagnosis and management of chronic myeloid leukaemia
  • Guidelines on the use of irradiated blood components
  • Diagnosis and Management of Hereditary Spherocytosis
  • Guideline for diagnosis and management of hairy cell leukaemia (HCL) and hairy cell variant (HCL-V)
  • Guidelines on the diagnosis, investigation and initial treatment of myeloma
  • Front‐line management of post‐transplantation lymphoproliferative disorder in adult solid organ recipient patients
  • GPP Preoperative patient blood management during the SARS‐CoV‐2 pandemic
  • Guidelines for the diagnosis and evaluation of prognosis of adult myelodysplastic syndromes
  • Guidelines for the management of adult myelodysplastic syndromes
  • GL Management of sickle cell disease in pregnancy
  • GPP Use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders
  • GPP Management of cardiovascular complications of bruton tyrosine kinase inhibitors
  • Clinical and laboratory diagnosis of heritable platelet disorders in adults and children
  • GPP Cytomegalovirus serological testing in potential allogeneic haematopoietic stem cell transplant recipients
  • Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias
  • Guideline The management of Castleman disease
  • GPP Richter transformation of chronic lymphocytic leukaemia
  • Good Practice Paper for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children
  • Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma)
  • Guidelines on the diagnosis and management of Waldenström macroglobulinaemia
  • Guideline for the first-line management of Classical Hodgkin Lymphoma
  • Guidelines for the laboratory diagnosis of malaria
  • Guideline for the treatment of chronic lymphocytic leukaemia
  • About our Guidelines
  • Proposing and writing a new BSH Guideline
  • For Guidelines writers and Taskforce Members
  • Archived Guidelines
  • Guidelines Listing Plain Text
  • Audio & written commentary
  • ASM Guidelines Videos
  • Membership
  • Membership Signup
  • Meet our members
  • Your career and wellbeing
  • British Journal of Haematology
  • BSH-EHA Joint Membership
  • Membership FAQs
  • Event Proposal
  • Membership Survey 2020
  • Grants
  • Annual Scientific Meeting Scholarships
  • ASM Scholarship Terms and Conditions
  • ASH-BSH Abstract Achievement Award
  • Cohort Study Grant
  • Early-Stage Research Start-up Grants
  • Early-Stage Research Start-up Grant Terms and Conditions
  • Global Haematology Scholarship
  • Global Haematology Scholarship Terms and Conditions
  • Meeting Support
  • Meeting Support Grant Terms and Conditions
  • Student Elective Scholarships
  • Student Elective Terms and Conditions
  • Trainee Educational Bursaries
  • Trainee Educational Bursaries Terms and Conditions
  • Travel Scholarships
  • Travel Scholarship Terms and Conditions
  • Visiting Fellow
  • Visiting Fellow Scholarship Terms and Conditions
  • Grants - our impact
  • Grants FAQs
  • Profile
  • Sign Up
  • Login
  • Login Success
  • Website Registration Required
  • Register Success
  • Forgot Password
  • Event Payment Confirmation
  • Event Payment Failed
  • Membership Payment Confirmation
  • Membership Payment Failed
  • Membership Signup Confirmation
  • Event Signup
  • Website Signup
  • Proposer Verification Confirmation
  • HTML Sitemap
  • Search
  • Sitemap
  • Member Renewal
  • Subscription Renewal Failed
  • Event Booking Failed
  • Member Submission Failed
  • Guidelines Declaration of Interest Form submission confirmation
  • Sounding Board sign up
  • Grant submission confirmation
  • Image submission
  • Subscription Renewal complete
  • error
  • Membership wizard
  • Processing Notice
  • Cookies
  • BSH Member access only
  • BSH at 60
  • Haematology timeline
  • 60 at 60 Exhibition
  • ‘All agreed’: Discover the story of the Society’s earliest days in 1960
  • Tools of the trade
  • Microscopes
  • Microscopes: from fleas to Fleming
  • 'Much like a honey-comb': discovering the cell
  • Microscopes: a collection
  • Pins and needles: aspiration and trephine needles through time
  • Measuring up: the invention of blood analysis
  • Early analytical equipment
  • Blood count through the ages
  • Blood sucking: the perils of the laboratory
  • Reflections on the pandemic
  • 60 at 60 contributions
  • Share your reflections
  • Signposting history
  • Snakes alive! How the Reptile House at London Zoo started a thirty-year medical mystery
  • BSH Past Presidents
  • Multidisciplinary Haematology Team
  • Building a Community
  • Overcoming Obstacles
  • Inspiring Others
  • Enhancing Care
  • Pioneering Research
  • BSH 2020 Gallery
  • Acknowledgements
  • Maintenance
  • Test Page
  • Access not permitted
  • Page not found
  • Workforce Report
  • Workforce report: Key Points
  • Full member access only
  • Event delegate access only
  • SIG Member access only
© British Society for Haematology 2022
The British Society for Haematology is registered in England and Wales as a Company Limited by Guarantee, No 02645706 and as a Charity, No 1005735 Registered Office and correspondence address: 100 White Lion Street London N1 9PF. Phone: 020 7713 0990
  • Terms
  • Processing Notice
  • Sitemap